Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,400
Closed -$1.07M 88
2026
Q1
$1.07M Buy
+12,400
New +$1.19M 0.04% 59
2023
Q1
Sell
-2,300
Closed -$179K 105
2022
Q4
$179K Sell
2,300
-9,600
-81% -$778K 0.02% 118
2022
Q3
$961K Sell
11,900
-300
-2% -$27K 0.08% 195
2022
Q2
$1.1M Sell
12,200
-39,100
-76% -$3.96M 0.08% 174
2022
Q1
$5.69M Buy
+51,300
New +$5.42M 0.22% 100
2021
Q4
Sell
-18,300
Closed -$2.29M 187
2021
Q3
$2.29M Buy
18,300
+10,700
+141% +$1.38M 0.15% 106
2021
Q2
$944K Buy
7,600
+4,700
+162% +$590K 0.1% 113
2021
Q1
$343K Buy
2,900
+1,600
+123% +$188K 0.03% 83
2020
Q4
$153K Buy
+1,300
New +$143K 0.01% 78

Other funds holding MDT

QVR's MDT Position: Q4 2025 in Review

QVR sold out of Medtronic (MDT) in Q4 2025, closing a stake of 1,681 shares — an estimated $160K sold.

QVR first reported a position in MDT in Q4 2020 and held it in 8 quarters. The position peaked at $457K in Q3 2022. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • QVR reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • QVR sold 1,681 Medtronic shares in Q4 2025, an estimated $160K.
  • QVR first reported a position in Medtronic in Q4 2020 and held it in 8 quarters.
  • QVR's Medtronic position peaked at $457K in Q3 2022.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on QVR's 13F filing for Q4 2025, filed 28 Jan 2026.